{
  "cards": [
    {
      "summary": "Patients on opioid therapy should be evaluated for benefits and harms within 1 to 4 weeks of starting opioid therapy and every 3 months or more subsequently.",
      "indicator": "warning",
      "detail": "No evaluation for benefits and harms associated with opioid therapy has been performed for the patient in the past 3 months",
      "source": {
        "label": "2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain",
        "url": "https://guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chronic-pain---united-states-2016#420"
      },
      "suggestions": [
        {
          "label": "Assessment of risk for opioid use procedure",
          "actions": [
            {
              "type": "create",
              "description": "No evaluation for benefits and harms associated with opioid therapy has been performed for the patient in the past 3 months",
              "resource": {
                "resourceType": "ProcedureRequest",
                "status": "draft",
                "intent": "order",
                "code": {
                  "coding": [
                    {
                      "system": "http://snomed.info/sct",
                      "code": "454281000124100",
                      "display": "Assessment of risk for opioid abuse (procedure)"
                    }
                  ]
                },
                "subject": {
                  "reference": "Patient/example-rec-07-sixtythree-of-past-ninety-days"
                }
              }
            }
          ]
        }
      ]
    }
  ]
}